Table 1 The panel of twelve disease outcomes in UK Biobank analyzed in the study
From: A polygenic score method boosted by non-additive models
Phenotype | ncase | ncontrol | case prevalence |
|---|---|---|---|
Rheumatoid arthritis | 8040 | 329,098 | 2.38% |
Psoriasis | 6595 | 330,543 | 1.96% |
Gout | 9462 | 327,676 | 2.81% |
Inflammatory bowel disease | 3703 | 333,435 | 1.10% |
Asthma | 48,234 | 288,904 | 14.31% |
All-cause dementia | 4987 | 332,151 | 1.48% |
Alzheimer’s disease | 2060 | 335,078 | 0.61% |
Atrial fibrillation | 25,839 | 311,299 | 7.66% |
Breast cancer | 14,870 | 181,027 | 7.59% |
Colorectal cancer | 6869 | 330,269 | 2.04% |
Coronary artery disease | 23,184 | 313,954 | 6.88% |
Type 2 diabetes | 25,589 | 311,549 | 7.59% |
